Sexually transmitted infections and HIV treatment adherence among HIV-infected males and females in the HIV-treatment center at the AMC.

Sexually transmitted infections and HIV treatment adherence among HIV-infected males and females in the HIV-treatment center at the AMC. - STI and HIV treatment adherence among HIV-infected males and females.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31094

Enrollment

1750

Registered

2007-09-25

Start date

2007-09-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexually transmitted infection.

Interventions

None listed

Eligibility

Age

12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Main study: * HIV-infectie * Heterosexual * 12 *18 years: informed consent from both parents and patiënt * * 18 years: informed consent

Exclusion criteria

Exclusion criteria: - No understanding of Dutch or English language - For women: pregnancy. In case of doubt a pregnancy test is offered

Design outcomes

Primary

Measure	Time frame
The main study parameters are: 1. STI prevalence and risk behaviour and their determinants among HIV-infected heterosexuals. 2. Changes in STI prevalence/ incidence and risk behaviour and their determinants over time in HIV-infected heterosexuals (in case of a follow-up study). 3. Social and sexual networks for STI spread. 4. STI prevalence and risk behaviour and their determinants among HIV-infected MSM (substudy 1). 5. Treatment adherence and potential risk factors for poor treatment adherence (substudy 2) 6. The local genital cytokine response during an STI (substudy 3)	—

Measure

Time frame

The main study parameters are: 1. STI prevalence and risk behaviour and their determinants among HIV-infected heterosexuals. 2. Changes in STI prevalence/ incidence and risk behaviour and their determinants over time in HIV-infected heterosexuals (in case of a follow-up study). 3. Social and sexual networks for STI spread. 4. STI prevalence and risk behaviour and their determinants among HIV-infected MSM (substudy 1). 5. Treatment adherence and potential risk factors for poor treatment adherence (substudy 2) 6. The local genital cytokine response during an STI (substudy 3)

—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results